Search results
Nicola Benedetti warns of Scottish arts sector crisis without £100m of funding
The Comet· 5 hours agoSpeaking to Holyrood Magazine, Benedetti, a violinist who has won multiple awards, warned the culture sector in Scotland faces a “very trepidatious time” due to funding issues. It comes after ...
Nicola Benedetti warns of Scottish arts sector crisis without £100m of funding
Evening News 24· 5 hours agoSpeaking to Holyrood Magazine, Benedetti, a violinist who has won multiple awards, warned the culture sector in Scotland faces a “very trepidatious time” due to funding issues. It comes after ...
Nicola Benedetti warns of Scottish arts sector crisis without £100m of funding
PA Media: Entertainment via Yahoo News UK· 5 hours agoThat was whittled down to 281 organisations with a total ask of £87.5 million but Creative Scotland...
Reasons to Retain Baxter International (BAX) in Your Portfolio Now
Zacks via Yahoo Finance UK· 5 hours agoBaxter International's (BAX) robust growth across all geographies, along with transformational...
Equity Demands Revealed: British Actors Union Seeks Residuals Revamp & End To Misuse Of “Special...
Deadline via Yahoo News UK· 6 hours agoEXCLUSIVE: A revamp of residuals, artificial intelligence provisions and an end to the misuse of...
Adeleke beams while crediting huge crowd for spurring her on to national record
The Irish Sun· 6 hours agoRHASIDAT ADELEKE admitted a bumper National Championships crowd gave her the extra gear to set a new...
Tour de France 2024 stage-by-stage guide: Route maps and profiles for all 21 days
The Independent via Yahoo News UK· 7 hours agoThe gradient averages only 5.3% but at 23km long, it is a draining slog of a climb to the top and...
What to watch on TV today: Monday 1 July, including Wimbledon
The Irish Sun· 8 hours agoCRACK open the strawberries and cream for a thrilling return to SW19. It must officially be summer...
Will CVS Stock Rebound To Levels Over $100 Seen In 2022?
Forbes· 9 hours agoCVS Health stock (NYSE: CVS) currently trades at $58 per share, 47% below its pre-inflation shock...
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
PharmiWeb· 9 hours ago4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in Helsinki New sub-analysis of PEARL data highlights potential ...